Ontology highlight
ABSTRACT: Background
Although immunoglobulin A nephropathy (IgAN) is one of the foremost primary glomerular disease, treatment of IgAN is still in infancy. Non-invasive biomarkers are urgently needed for IgAN diagnosis. We investigate the difference in expression profiles of exosomal long non-coding-RNAs (lncRNAs) in plasma from IgAN patients compared with their healthy first-degree relatives, which may reveal novel non-invasive IgAN biomarkers.Methods
We isolated exosomes from the plasma of both IgAN patients and their healthy first-degree relatives. High-throughput RNA sequencing and real-time quantitative polymerase chain reaction (qRT-PCR) was used to validate lncRNA expression profiles. Pathway enrichment analysis was used to predict their nearest protein-coding genes.Results
lncRNA-G21551 was significantly down-regulated in IgAN patients. Interestingly, the nearest protein-coding gene of lncRNA-G21551 was found to be encoding the low affinity receptor of the Fc segment of immunoglobulin G (FCGR3B).Conclusions
Exosomal lncRNA-G21551, with FCGR3B as the nearest protein-coding gene, was down-regulated in IgAN patients, indicating its potential to serve as a non-invasive biomarker for IgAN.
SUBMITTER: Guo N
PROVIDER: S-EPMC7110735 | biostudies-literature | 2020 Mar
REPOSITORIES: biostudies-literature
Guo Na N Zhou Qin Q Huang Xiang X Yu Jianwen J Han Qianqian Q Nong Baoting B Xiong Yuanyan Y Liang Peifen P Li Jiajia J Feng Min M Lv Jun J Yang Qiongqiong Q Yang Qiongqiong Q
BMC immunology 20200331 1
<h4>Background</h4>Although immunoglobulin A nephropathy (IgAN) is one of the foremost primary glomerular disease, treatment of IgAN is still in infancy. Non-invasive biomarkers are urgently needed for IgAN diagnosis. We investigate the difference in expression profiles of exosomal long non-coding-RNAs (lncRNAs) in plasma from IgAN patients compared with their healthy first-degree relatives, which may reveal novel non-invasive IgAN biomarkers.<h4>Methods</h4>We isolated exosomes from the plasma ...[more]